| Human-IgG-neutralizing monoclonal antibodies block the SARS-CoV-2 infection J Wan, S Xing, L Ding, Y Wang, C Gu, Y Wu, B Rong, C Li, S Wang, ... Cell reports 32 (3), 2020 | 169 | 2020 |
| Ribosome 18S m6A methyltransferase METTL5 promotes translation initiation and breast cancer cell growth B Rong, Q Zhang, J Wan, S Xing, R Dai, Y Li, J Cai, J Xie, Y Song, J Chen, ... Cell reports 33 (12), 2020 | 92 | 2020 |
| PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma CY Wei, MX Zhu, PF Zhang, XY Huang, JK Wan, XZ Yao, ZT Hu, XQ Chai, ... Journal of Hepatology 77 (1), 163-176, 2022 | 72 | 2022 |
| The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2 C Li, X Tian, X Jia, J Wan, L Lu, S Jiang, F Lan, Y Lu, Y Wu, T Ying Signal Transduction and Targeted Therapy 6 (1), 132, 2021 | 34 | 2021 |
| PGAM1 inhibition promotes HCC ferroptosis and synergizes with anti‐PD‐1 immunotherapy Y Zheng, Y Wang, Z Lu, J Wan, L Jiang, D Song, C Wei, C Gao, G Shi, ... Advanced Science 10 (29), 2301928, 2023 | 20 | 2023 |
| A novel quantitative electrocardiography strategy reveals the electroinhibitory effect of tamoxifen on the mouse heart M Xie, S Zhu, G Liu, Y Wu, W Zhou, D Yu, J Wan, S Xing, S Wang, L Gan, ... Journal of Cardiovascular Translational Research 16 (5), 1232-1248, 2023 | 3 | 2023 |
| Antibodies to sars-coronavirus (covid-19) s1 spike protein LU Yanan, F Lan, J Xu, X Zhao, D Longfei, W Yongheng, WAN Jinkai, ... US Patent App. 17/053,008, 2021 | 2 | 2021 |
| The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation M Lin, X Zheng, J Yan, F Huang, Y Chen, R Ding, J Wan, L Zhang, ... Nature Communications 15 (1), 4995, 2024 | | 2024 |
